Alzheimer's Disease Clinical Trials in Los Angeles, CA

44 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type	Phase 3	Suven Life Sciences Limited	<1 mi
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)	Phase 3	Karuna Therapeutics	<1 mi
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)	—	University of Southern California	<1 mi
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)	Phase 2	Alzheimer's Disease Cooperative Study (ADCS)	<1 mi
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)	Phase 3	Karuna Therapeutics	<1 mi
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD	Phase 3	Annovis Bio Inc.	<1 mi
Longitudinal Early-onset Alzheimer's Disease Study Protocol	—	Indiana University	<1 mi
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD	Phase 1	Butler Hospital	<1 mi
[18F]PI-2620 Phase 3 Histopathological Study	Phase 3	Life Molecular Imaging Ltd	<1 mi
Polyphenols and Cognitive Decline	N/A	University of California, Los Angeles	<1 mi
Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)	Phase 1/2	University of California, Los Angeles	<1 mi
Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.	N/A	University of Southern California	<1 mi
Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease	N/A	University of California, Los Angeles	<1 mi
Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study	N/A	Cedars-Sinai Medical Center	<1 mi
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers	N/A	University of California, Los Angeles	<1 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant	Phase 3	Eidos Therapeutics, a BridgeBio company	<1 mi
Cardiac-Control Affecting Learning Through Mindfulness (CALM)	N/A	University of Southern California	<1 mi
Music-Based Interventions, Aging, Alzheimer's Disease	N/A	University of Southern California	<1 mi
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease	Phase 1/2	NKGen Biotech, Inc.	6 mi
Open-Label Extension Protocol to SNK01-AD01 Study	Phase 2	NKGen Biotech, Inc.	6 mi
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)	Phase 3	Karuna Therapeutics	9 mi
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)	Phase 3	Bristol-Myers Squibb	9 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)	Phase 3	Bristol-Myers Squibb	9 mi
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies	Phase 3	Hoffmann-La Roche	9 mi
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)	Phase 3	Bristol-Myers Squibb	9 mi
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)	Phase 2	Merck Sharp & Dohme LLC	9 mi
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease	Phase 3	Hoffmann-La Roche	9 mi
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions	Phase 1/2	Thomas Advanced Medical LLC	9 mi
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)	Phase 2	Merck Sharp & Dohme LLC	14 mi
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease	Phase 3	Hoffmann-La Roche	14 mi
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease	Phase 2	Celgene	14 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)	Phase 3	Bristol-Myers Squibb	16 mi
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease	Phase 2	Intra-Cellular Therapies, Inc.	20 mi
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)	Phase 1	Eli Lilly and Company	20 mi
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease	Phase 3	Bristol-Myers Squibb	20 mi
ACP-204 in Adults With Alzheimer's Disease Psychosis	Phase 2/3	ACADIA Pharmaceuticals Inc.	24 mi
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia	Phase 2	Intra-Cellular Therapies, Inc.	24 mi
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis	Phase 2	MapLight Therapeutics	24 mi
A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01	Phase 1	Alzheimer's Disease Expert Lab (ADEL), Inc.	24 mi
Trial-Ready Cohort-Down Syndrome (TRC-DS)	—	University of Southern California	29 mi
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders	N/A	University of Michigan	29 mi
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease	Phase 2	University of Arizona	30 mi
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease	Phase 1	Regeneration Biomedical, Inc.	35 mi
Biomarker Exploration in Aging, Cognition and Neurodegeneration	Phase 3	University of California, Irvine	36 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.